FDA Drug Recalls

Recalls / Class II

Class IID-0136-2023

Product

Ciprofloxacin Ophthalmic Solution, USP 0.3% (Ciprofloxacin HCl), 2.5mL per bottle, Rx Only, Manufactured by: Akorn, Inc., Lake Forest, IL 60045. NDC: 17478-714-25

Affected lot / code info
Lot: Lot 1E22A, EXP 10/31/2022

Why it was recalled

CGMP Deviations:

Recalling firm

Firm
Akorn, Inc.
Notification channel
Letter
Type
Voluntary: Firm initiated
Address
5605 Centerpoint Ct Ste A, N/A, Gurnee, Illinois 60031-5278

Distribution

Quantity
1,584 bottles
Distribution pattern
Nationwide in the USA

Timeline

Recall initiated
2022-10-13
FDA classified
2023-01-13
Posted by FDA
2023-01-25
Status
Ongoing

Source: openFDA Drug Enforcement endpoint. Recall record D-0136-2023. The FDA issues recall classifications as health-hazard assessments, not legal findings; for legal claims consult a licensed attorney.

Class II recall: drug · FDA Drug Recalls